Catalyst Wire Dossier Catalyst Wire Dossier

Group B Meningococcal Vaccine

· U.S. Army Medical Research and Development Command
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Group B Meningococcal Vaccine, covering 2018-10-29 to 2018-10-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. [Phase 1]

See pricing